Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication

Journal of Comparative Neurology

Volumn 521, Issue 10, 2013, Pages 2235-2261

  Gu, Guibao ^a   Roland, Barbara ^a   Tomaselli, Kevin ^a   Dolman, Carrie S ^a   Lowe, Carolyn ^a   Heilig, Joseph S ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Exendin 4; GLP 1; GLP 2; Metabolism; Pathway

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; PROTEIN FOS;

ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; FOREBRAIN; HYPOTHALAMUS NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE PROJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RHOMBENCEPHALON; SOLITARY TRACT NUCLEUS;

ANIMALS; AREA POSTREMA; BRAIN; GENE EXPRESSION; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; HYPOGLYCEMIC AGENTS; MALE; ONCOGENE PROTEINS V-FOS; PEPTIDE FRAGMENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; VENOMS;

EID: 84876715030     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23282     Document Type: Article

References (139)

1. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR. 2005. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044: 127-131.
2. Abercrombie M. 1946. Estimation of nuclear population from microtome sections. Anat Rec 94: 239-247.
3. Acuna-Goycolea C, van den Pol A. 2004. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 24: 8141-8152.
4. Agnati LF, Zoli M, Stromberg I, Fuxe K. 1995. Intercellular communication in the brain: wiring versus volume transmission. Neuroscience 69: 711-726.
5. Ahn S, Phillips AG. 2002. Modulation by central and basolateral amygdalar nuclei of dopaminergic correlates of feeding to satiety in the rat nucleus accumbens and medial prefrontal cortex. J Neurosci 22: 10958-10965.
6. Anand BK, Brobeck JR. 1951. Hypothalamic control of food intake in rats and cats. Yale J Biol Med 24: 123-140.
7. Aravich PF, Sclafani A. 1983. Paraventricular hypothalamic lesions and medial hypothalamic knife cuts produce similar hyperphagia syndromes. Behav Neurosci 97: 970-983.
8. Balkan B, Li X. 2000. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol Regul Integr Comp Physiol 279: R1449-1454.
9. Baraboi ED, Smith P, Ferguson AV, Richard D. 2010. Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist. Am J Physiol Regul Integr Comp Physiol 298: R1098-1110.
10. Baraboi ED, St-Pierre DH, Shooner J, Timofeeva E, Richard D. 2011. Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4. Am J Physiol Regul Integr Comp Physiol 301: R1011-1024.
11. Barrera JG, Jones KR, Herman JP, D'Alessio DA, Woods SC, Seeley RJ. 2011. Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function. J Neurosci 31: 3904-3913.
12. Beak SA, Heath MM, Small CJ, Morgan DG, Ghatei MA, Taylor AD, Buckingham JC, Bloom SR, Smith DM. 1998. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest 101: 1334-1341.
13. Bester H, Besson JM, Bernard JF. 1997. Organization of efferent projections from the parabrachial area to the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J Comp Neurol 383: 245-281.
14. Bester H, Bourgeais L, Villanueva L, Besson JM, Bernard JF. 1999. Differential projections to the intralaminar and gustatory thalamus from the parabrachial area: a PHA-L study in the rat. J Comp Neurol 405: 421-449.
15. Bubser M, Deutch AY. 1999. Stress induces Fos expression in neurons of the thalamic paraventricular nucleus that innervate limbic forebrain sites. Synapse 32: 13-22.
16. Bullock BP, Heller RS, Habener JF. 1996. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137: 2968-2978.
17. Buse JB, Drucker DJ, Taylor KL, Kim T, Walsh B, Hu H, Wilhelm K, Trautmann M, Shen LZ, Porter LE. 2010. DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks. Diabetes Care 33: 1255-1261.
18. Ciccocioppo R, Fedeli A, Economidou D, Policani F, Weiss F, Massi M. 2003. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J Neurosci 23: 9445-9451.
19. Davidson MB, Bate G, Kirkpatrick P. 2005. Exenatide. Nat Rev Drug Discov 4: 713-714.
20. de Olmos JS, Heimer L. 1999. The concepts of the ventral striatopallidal system and extended amygdala. Ann N Y Acad Sci 877: 1-32.
21. Deacon CF, Pridal L, Klarskov L, Olesen M, Holst JJ. 1996. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol 271(3 Pt 1): E458-464.
22. Dossat AM, Lilly N, Kay K, Williams DL. 2011. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 31: 14453-14457.
23. Drucker DJ. 2001. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. Curr Pharm Des 7: 1399-1412.
24. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. 1987. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 84: 3434-3438.
25. Drucker DJ, Dritselis A, Kirkpatrick P. 2010. Liraglutide. Nat Rev Drug Discov 9: 267-268.
26. Dunphy JL, Taylor RG, Fuller PJ. 1998. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol Cell Endocrinol 141: 179-186.
27. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN. 2003. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 9: 1173-1179.
28. Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R, Goke B. 1992. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22: 283-291.
29. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE, Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M, Elmquist JK. 1998. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402: 442-459.
30. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK. 1999. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23: 775-786.
31. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, Elmquist JK. 2000. Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423: 261-281.
32. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB. 1997. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 138: 839-842.
33. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB. 1998a. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci U S A 95: 741-746.
34. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. 1998b. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 395: 535-547.
35. Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R, Friedman JM. 1997. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A 94: 7001-7005.
36. Fulwiler CE, Saper CB. 1984. Subnuclear organization of the efferent connections of the parabrachial nucleus in the rat. Brain Res 319: 229-259.
37. Gerfen CR, Sawchenko PE. 1984. An anterograde neuroanatomical tracing method that shows the detailed morphology of neurons, their axons and terminals: immunohistochemical localization of an axonally transported plant lectin, Phaseolus vulgaris leucoagglutinin (PHA-L). Brain Res 290: 219-238.
38. Goke R, Larsen PJ, Mikkelsen JD, Sheikh SP. 1995. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7: 2294-2300.
39. Groenewegen HJ. 1988. Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience 24: 379-431.
40. Groenewegen HJ, Witter MP. 2004. Thalamus. In: Paxinos G, editor. The rat nervous system, 3rd ed. Amsterdam: Elsevier. p 407-453.
41. Gu G, Roland BL, Vu C, Turek VF, Phelps J, Knott C, Gai W, Nikoulina S, Lowe C, Tomaselli K. 2009. Does peripherally dosed exendin-4 activate endogenous GLP-1 system in the brain? Chicago: Soc Neurosci Abstr. p 470.420.
42. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. 1998. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18: 559-572.
43. Han VK, Hynes MA, Jin C, Towle AC, Lauder JM, Lund PK. 1986. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J Neurosci Res 16: 97-107.
44. Hansen L, Deacon CF, Orskov C, Holst JJ. 1999. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140: 5356-5363.
45. Herkenham M. 1987. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience 23: 1-38.
46. Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R, Goke B. 1995. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56: 117-126.
47. Holst JJ. 2007. The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439.
48. Holst JJ, Deacon CF. 2005. Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 48: 612-615.
49. Hsu SM, Raine L. 1981. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29: 1349-1353.
50. Hsu SM, Raine L, Fanger H. 1981. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75: 816-821.
51. Hurley KM, Herbert H, Moga MM, Saper CB. 1991. Efferent projections of the infralimbic cortex of the rat. J Comp Neurol 308: 249-276.
52. Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK. 1988. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 271: 519-532.
53. Kastin AJ, Akerstrom V. 2003. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 27: 313-318.
54. Kastin AJ, Akerstrom V, Pan W. 2002. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 18: 7-14.
55. Kieffer TJ, Habener JF. 1999. The glucagon-like peptides. Endocr Rev 20: 876-913.
56. Kinzig KP, D'Alessio DA, Seeley RJ. 2002. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci 22: 10470-10476.
57. Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Gremeaux T, Drucker DJ, Kahn CR, Girard J, Tanti JF, Delzenne NM, Postic C, Burcelin R. 2005. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 115: 3554-3563.
58. Knauf C, Cani PD, Kim DH, Iglesias MA, Chabo C, Waget A, Colom A, Rastrelli S, Delzenne NM, Drucker DJ, Seeley RJ, Burcelin R. 2008. Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. Diabetes 57: 2603-2612.
59. Kreymann B, Williams G, Ghatei MA, Bloom SR. 1987. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2: 1300-1304.
60. Krout KE, Belzer RE, Loewy AD. 2002. Brainstem projections to midline and intralaminar thalamic nuclei of the rat. J Comp Neurol 448: 53-101.
61. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. 1997a. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77: 257-270.
62. Larsen PJ, Tang-Christensen M, Jessop DS. 1997b. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138: 4445-4455.
63. Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M. 2001. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 50: 2530-2539.
64. Leibowitz SF, Hammer NJ, Chang K. 1981. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol Behav 27: 1031-1040.
65. Liu H, Brown JL, Jasmin L, Maggio JE, Vigna SR, Mantyh PW, Basbaum AI. 1994. Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc Natl Acad Sci U S A 91: 1009-1013.
66. Lovshin J, Estall J, Yusta B, Brown TJ, Drucker DJ. 2001. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem 276: 21489-21499.
67. Mack CM, Moore CX, Jodka CM, Bhavsar S, Wilson JK, Hoyt JA, Roan JL, Vu C, Laugero KD, Parkes DG, Young AA. 2006. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int J Obes (Lond) 30: 1332-1340.
68. MacLusky NJ, Cook S, Scrocchi L, Shin J, Kim J, Vaccarino F, Asa SL, Drucker DJ. 2000. Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology 141: 752-762.
69. Marre M, Shaw J, Brandle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S. 2009. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabet Med 26: 268-278.
70. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P. 1996. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8: 733-735.
71. Merchenthaler I, Lane M, Shughrue P. 1999. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403: 261-280.
72. Minano FJ, Meneres Sancho MS, Sancibrian M, Salinas P, Myers RD. 1992. GABAA receptors in the amygdala: role in feeding in fasted and satiated rats. Brain Res 586: 104-110.
73. Moga MM, Moore RY. 1997. Organization of neural inputs to the suprachiasmatic nucleus in the rat. J Comp Neurol 389: 508-534.
74. Mojsov S, Weir GC, Habener JF. 1987. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79: 616-619.
75. Nakagawa A, Satake H, Nakabayashi H, Nishizawa M, Furuya K, Nakano S, Kigoshi T, Nakayama K, Uchida K. 2004. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 110: 36-43.
76. Nogueiras R, Perez-Tilve D, Veyrat-Durebex C, Morgan DA, Varela L, Haynes WG, Patterson JT, Disse E, Pfluger PT, Lopez M, Woods SC, DiMarchi R, Dieguez C, Rahmouni K, Rohner-Jeanrenaud F, Tschop MH. 2009. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity. J Neurosci 29: 5916-5925.
77. Norgren R. 1976. Taste pathways to hypothalamus and amygdala. J Comp Neurol 166: 17-30.
78. Otake K, Ruggiero DA, Nakamura Y. 1995. Adrenergic innervation of forebrain neurons that project to the paraventricular thalamic nucleus in the rat. Brain Res 697: 17-26.
79. Otake K, Kin K, Nakamura Y. 2002. Fos expression in afferents to the rat midline thalamus following immobilization stress. Neurosci Res 43: 269-282.
80. Panula P, Pirvola U, Auvinen S, Airaksinen MS. 1989. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28: 585-610.
81. Petrovich GD, Ross CA, Mody P, Holland PC, Gallagher M. 2009. Central, but not basolateral, amygdala is critical for control of feeding by aversive learned cues. J Neurosci 29: 15205-15212.
82. Pfaffmann C, Frank M, Norgren R. 1979. Neural mechanisms and behavioral aspects of taste. Annu Rev Psychol 30: 283-325.
83. Phelps JL, Blase EK, Koda JE. 1996. Development and characterization of monoclonal antibodies specific for amylin. Hybridoma 15: 379-386.
84. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E. 1996. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380: 243-247.
85. Rinaman L. 1999a. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia. Am J Physiol 277(5 Pt 2): R1537-1540.
86. Rinaman L. 1999b. Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am J Physiol 277(2 Pt 2): R582-590.
87. Rinaman L. 2010. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 1350: 18-34.
88. Rowland NE, Crews EC, Gentry RM. 1997. Comparison of Fos induced in rat brain by GLP-1 and amylin. Regul Pept 71: 171-174.
89. Ruttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W. 2009. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 150: 1174-1181.
90. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585.
91. Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ. 2008. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57: 2046-2054.
92. Saper CB. 1982. Reciprocal parabrachial-cortical connections in the rat. Brain Res 242: 33-40.
93. Saper CB. 2004. Central autonomic system. In: Paxinos G, editor. The rat nervous system, 3rd ed. Amsterdam: Elsevier. p 761-796.
94. Saper CB, Swanson LW, Cowan WM. 1976. The efferent connections of the ventromedial nucleus of the hypothalamus of the rat. J Comp Neurol 169: 409-442.
95. Saper CB, Swanson LW, Cowan WM. 1979. An autoradiographic study of the efferent connections of the lateral hypothalamic area in the rat. J Comp Neurol 183: 689-706.
96. Saper CB, Chou TC, Elmquist JK. 2002. The need to feed: homeostatic and hedonic control of eating. Neuron 36: 199-211.
97. Sarkar S, Fekete C, Legradi G, Lechan RM. 2003. Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res 985: 163-168.
98. Sawchenko PE. 1998. Toward a new neurobiology of energy balance, appetite, and obesity: the anatomists weigh in. J Comp Neurol 402: 435-441.
99. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. 1996. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98: 1101-1106.
100. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. 2000. Central nervous system control of food intake. Nature 404: 661-671.
101. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ. 1996. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2: 1254-1258.
102. Seeley RJ, Woods SC. 2003. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci 4: 901-909.
103. Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC, D'Alessio D. 2000. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci 20: 1616-1621.
104. Sesack SR, Deutch AY, Roth RH, Bunney BS. 1989. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290: 213-242.
105. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. 1998. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396: 670-674.
106. Shimizu I, Hirota M, Ohboshi C, Shima K. 1987. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology 121: 1076-1082.
107. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR. 2010. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 151: 1588-1597.
108. Simerly RB. 2004. Anatomical substrates of hypothalamic integration. In: Paxinos G, editor. The rat nervous system, 3rd ed. Amsterdam: Elsevier. p 335-368.
109. Simerly RB, Swanson LW. 1988. Projections of the medial preoptic nucleus: a Phaseolus vulgaris leucoagglutinin anterograde tract-tracing study in the rat. J Comp Neurol 270: 209-242.
110. Stricker EM, Swerdloff AF, Zigmond MJ. 1978. Intrahypothalamic injections of kainic acid produce feeding and drinking deficits in rats. Brain Res 158: 470-473.
111. Swanson LW. 2004. Brain maps: structure of the rat brain. Amsterdam: Elsevier.
112. Takada M, Campbell KJ, Moriizumi T, Hattori T. 1990. On the origin of the dopaminergic innervation of the paraventricular thalamic nucleus. Neurosci Lett 115: 33-36.
113. Takaki A, Aou S, Oomura Y, Okada E, Hori T. 1992. Feeding suppression elicited by electrical and chemical stimulations of monkey hypothalamus. Am J Physiol 262(4 Pt 2): R586-594.
114. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL. 2005. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146: 3748-3756.
115. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP. 1996. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271(4 Pt 2): R848-856.
116. Tang-Christensen M, Larsen PJ, Thulesen J, Romer J, Vrang N. 2000. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 6: 802-807.
117. Tang-Christensen M, Vrang N, Larsen PJ. 2001. Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int J Obes Relat Metab Disord 25(Suppl 5): S42-47.
118. Ter Horst GJ, de Boer P, Luiten PG, van Willigen JD. 1989. Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience 31: 785-797.
119. Thiele TE, Van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein IL, Seeley RJ. 1997. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol 272(2 Pt 2): R726-730.
120. Touzani K, Taghzouti K, Velley L. 1997. Increase of the aversive value of taste stimuli following ibotenic acid lesion of the central amygdaloid nucleus in the rat. Behav Brain Res 88: 133-142.
121. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. 1996. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72.
122. Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, Ellis KS, Woods SC, Seeley RJ, Herman JP, D'Alessio DA. 2007. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 148: 4965-4973.
123. van der Kooy D, Koda LY. 1983. Organization of the projections of a circumventricular organ: the area postrema in the rat. J Comp Neurol 219: 328-338.
124. Van der Werf YD, Witter MP, Groenewegen HJ. 2002. The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev 39: 107-140.
125. Vertes RP. 1992. PHA-L analysis of projections from the supramammillary nucleus in the rat. J Comp Neurol 326: 595-622.
126. Vrang N, Larsen PJ. 2010. Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides. Prog Neurobiol 92: 442-462.
127. Vrang N, Phifer CB, Corkern MM, Berthoud HR. 2003. Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. Am J Physiol Regul Integr Comp Physiol 285: R470-478.
128. Vrang N, Hansen M, Larsen PJ, Tang-Christensen M. 2007. Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei. Brain Res 1149: 118-126.
129. Vrang N, Jelsing J, Raun K, Bjerre J, Knudsen L. 2011. The effect of liraglutide on gastric emptying and body weight is neither mediated by vagal afferents nor the area postrema. Abstract of 47th European Association for the Study of Diabetes 2011 (EASD). Lisbon, Portugal.
130. Watts AG, Swanson LW. 1987. Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J Comp Neurol 258: 230-252.
131. Watts AG, Swanson LW, Sanchez-Watts G. 1987. Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat. J Comp Neurol 258: 204-229.
132. Wei Y, Mojsov S. 1995. Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 358: 219-224.
133. Williams DL. 2009. Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. Endocrinology 150: 2997-3001.
134. Williams KW, Scott MM, Lee CE, Elias CF, Elmquist JK. 2010. Regulation of central glucagon-like peptide-1 system. San Diego: Soc Neurosci Abstr. p 191.115.
135. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, Elmquist JK. 2002. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest 110: 43-52.
136. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK. 2003. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci 23: 2939-2946.
137. Yang L, Scott KA, Hyun J, Tamashiro KL, Tray N, Moran TH, Bi S. 2009. Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J Neurosci 29: 179-190.
138. Young AA. 2002. No effect of exendin-4 on blood pressure in man. J Clin Invest eLetter.
139. Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B, Denaro M. 1999. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 48: 1026-1034.